Clifford Chance | Amended Good Supply Practice (GSP) Standards Set to Impact Pharmaceutical Distribution Sector

1 October 2011

Amended Good Supply Practice (GSP) Standards Set to Impact Pharmaceutical Distribution Sector

Download File

Amended Good Supply Practice (GSP) Standards Set to Impact Pharmaceutical Distribution Sector

Related Papers

Co-promotion arrangements in China's pharmaceutical and biotech industries

On 1 August 2011, the State Food and Drug Administration (SFDA) issued a notice seeking public comments on the Amended Good Supply Practices for Pharmaceutical Products (Draft for Comments) (Draft GSP Standards) (in Chinese 药品经营质量管理规范(征求意见稿)). Below we set out the key features of the Draft GSP Standards and consider their potential impact on the pharmaceutical distribution industry in China.

Download Full Report